42m
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small ...
Ingram Micro Holding Corporation (the "Company") today announced that Ingram Holdco, LLC, an affiliate of Platinum Equity, LLC (the "Selling Stockholder"), has commenced a secondary offering of $200 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results